A health worker prepares to inoculate a volunteer with Sinopharm’s Covid-19 vaccine during a trial in Peru. Photo: AFP
After the coronavirus research race, vaccine producers face new hurdles
- Production challenges differ widely between the traditional vaccines developed in China and advanced mRNA products
- Chinese vaccines have advantage in the short-term until supply chain issues for new technology versions are resolved
Topic |
Coronavirus vaccine
A health worker prepares to inoculate a volunteer with Sinopharm’s Covid-19 vaccine during a trial in Peru. Photo: AFP